Precision Irrigation Market - A Global and Regional Analysis: Focus on Product, Application, and Country Analysis - Analysis and Forecast, 2022-2027
Global Precision Irrigation Market Industry Overview
The global precision irrigation market was valued at $2,238.7 million in 2022 and is forecast to reach $4,471.2 million by 2027 at a CAGR of 14.84%. Owing to the growing demand for food and grains, the growth in the precision irrigation market is expected to be driven by the increasing adoption of digital and smart agriculture equipment and technologies. Some of the primary benefits related to precision irrigation market in the agricultural field include yield monitoring and field mapping, crop scouting, weather tracking and forecasting, irrigation management, and farm economics.
Market Lifecycle Stage
The precision irrigation market is in a growth phase. Since 2010, the adoption of precision irrigation has increased, especially by medium and large-scale farmers. Increased awareness regarding the benefits of precision irrigation market has increased the adoption rate of these solutions. High technological advancement in some regions of the world is another driver toward the adoption of precision irrigation by farmers.
Impact
In precision irrigation, by delivering water and nutrients directly to the roots of plants, farmers can cultivate healthier crops and get bigger yields, which helps them to meet the growing demand for food without using up limited resources. This enhances the wide acceptance of precision irrigation among farmers.
Precision irrigation enables farmers to increase profitability by achieving higher yields per hectare, better-quality crops, while using less water, fertilizer, and energy. It helps farmers save water and reduce their water bills by avoiding over-watering their crops, which can lead to water waste and increased costs.
Market Segmentation:
Segmentation 1: by Site of Operation
Segmentation 2: by Method of Irrigation
Segmentation 3: by Solution
Segmentation 4: by Region
Recent Developments in Global Precision Irrigation Market
Following are the demand drivers for the precision irrigation market:
Product/Innovation Strategy: The product segment helps to identify the needs of customers. The strategy focus on the specific needs of farmers, including water conservation, cost savings, and increased crop yields. By understanding the needs of the customer, the research report provides targeted and relevant information that addresses these needs.
Growth/Marketing Strategy: The precision irrigation market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been business expansion to strengthen their positions in the precision irrigation market. For instance, in May 2021, Valmont Industries, Inc. acquired Prospera Technologies, which is an Israel-based artificial intelligence provider. The transaction was valued at approximately $300 million. Valmont and Prospera integrated AI technologies with center pivot irrigation in order to develop real-time crop analysis along with anomaly detection solutions, which resulted in strong adoption as well as greater returns for the grower.
Competitive Strategy: Key players in the precision irrigation market analyzed and profiled in the study involve precision irrigation service providers that provide tools and technologies. Moreover, a detailed competitive benchmarking of the players operating in the global precision irrigation market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, and market penetration.
Key Companies Profiled
The global precision irrigation market was valued at $2,238.7 million in 2022 and is forecast to reach $4,471.2 million by 2027 at a CAGR of 14.84%. Owing to the growing demand for food and grains, the growth in the precision irrigation market is expected to be driven by the increasing adoption of digital and smart agriculture equipment and technologies. Some of the primary benefits related to precision irrigation market in the agricultural field include yield monitoring and field mapping, crop scouting, weather tracking and forecasting, irrigation management, and farm economics.
Market Lifecycle Stage
The precision irrigation market is in a growth phase. Since 2010, the adoption of precision irrigation has increased, especially by medium and large-scale farmers. Increased awareness regarding the benefits of precision irrigation market has increased the adoption rate of these solutions. High technological advancement in some regions of the world is another driver toward the adoption of precision irrigation by farmers.
Impact
In precision irrigation, by delivering water and nutrients directly to the roots of plants, farmers can cultivate healthier crops and get bigger yields, which helps them to meet the growing demand for food without using up limited resources. This enhances the wide acceptance of precision irrigation among farmers.
Precision irrigation enables farmers to increase profitability by achieving higher yields per hectare, better-quality crops, while using less water, fertilizer, and energy. It helps farmers save water and reduce their water bills by avoiding over-watering their crops, which can lead to water waste and increased costs.
Market Segmentation:
Segmentation 1: by Site of Operation
- On-Field
- Controlled Environment Agriculture
Segmentation 2: by Method of Irrigation
- Drip Irrigation
- Sprinkler Irrigation
- Others
Segmentation 3: by Solution
- Hardware
- Software
- Services
Segmentation 4: by Region
- North America - U.S., Canada, Mexico and Rest-of-North America
- Europe - Germany, France, Netherlands, Belgium, Switzerland, Greece, Ukraine, Turkey and Rest-of-Europe
- China
- U.K.
- Asia-Pacific - India, Japan, Australia, and Rest-of-Asia-Pacific
- Middle East and Africa - Israel, South Africa and Rest-of-Middle East and Africa
- South America - Brazil, Argentina and Rest-of-South America
Recent Developments in Global Precision Irrigation Market
- In June 2022, Rivulis and Jain Irrigation Systems Ltd.’s subsidiary Jain International Trading merged with an aim to have definitive transaction agreements.
- In February 2022, CALSENSE introduced irrigation management as a service or IMaaS. IMaaS consists of a unique and valuable way of irrigation management, which removes the need for customers to secure funds for purchasing smart irrigation controllers, sensors, and software.
- In May 2022, HUNTER INDUSTRIES launched a 12' eco-indicator that offers greater visibility from a distance. Eco-Indicator makes it quicker and easier to verify system operation from afar. The rugged 12' device also provides a convenient visual signal when the system is pressurized also running. Its further elevated height offers a clear line of sight over tall shrubs, flowers, as well as grasses.
- In March 2022, HydroPoint and Aliaxis partnered for smart water management. Through this partnership, Aliaxis and HydroPoint joined forces in the field of smart irrigation systems along with leak and flow monitoring services for the building industry. The new partnership would further allow both companies to build upon each other’s strengths.
Following are the demand drivers for the precision irrigation market:
- Need for Optimal Water Usage in Agriculture
- Decreasing Labor Force in Agriculture
- Increasing Adoption of Fertigation and Chemigation
- High Initial Investment
- Lack of Technological Infrastructure
Product/Innovation Strategy: The product segment helps to identify the needs of customers. The strategy focus on the specific needs of farmers, including water conservation, cost savings, and increased crop yields. By understanding the needs of the customer, the research report provides targeted and relevant information that addresses these needs.
Growth/Marketing Strategy: The precision irrigation market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been business expansion to strengthen their positions in the precision irrigation market. For instance, in May 2021, Valmont Industries, Inc. acquired Prospera Technologies, which is an Israel-based artificial intelligence provider. The transaction was valued at approximately $300 million. Valmont and Prospera integrated AI technologies with center pivot irrigation in order to develop real-time crop analysis along with anomaly detection solutions, which resulted in strong adoption as well as greater returns for the grower.
Competitive Strategy: Key players in the precision irrigation market analyzed and profiled in the study involve precision irrigation service providers that provide tools and technologies. Moreover, a detailed competitive benchmarking of the players operating in the global precision irrigation market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, and market penetration.
Key Companies Profiled
- Rivulis
- CALSENSE
- Galcon
- Holman Industries
- HUNTER INDUSTRIES
- HydroPoint
- Jain Irrigation Systems Ltd.
- K-Rain
- Lindsay Corporation
- Nelson Irrigation
- NETAFIM
- Rachio inc.
- Rain Bird Corporation
- The Toro Company
- Valmont Industries, Inc.
- Trimble Inc.
- Prospera Technologies
- CropX Inc.
- Pycno
- Arable
- Acuity Agriculture
1 MARKET
1.1 Global Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.2.1 Inclusion Criteria
1.1.2.2 Exclusion Criteria
1.1.3 Market Overview
1.1.3.1 Market Footprint
1.1.3.2 Market Size and Future Growth Potential
1.1.4 COVID-19 Impact on the Market
1.1.4.1 Impact on Research and Clinical Operations
1.1.4.2 COVID-19 Impact: Current Scenario of the Market
1.2 Industry Analysis
1.2.1 Regulatory Framework
1.2.1.1 Legal Requirements and Framework in the U.S.
1.2.1.2 Legal Requirements and Framework in Europe
1.2.1.2.1 U.K.
1.2.1.2.2 Spain
1.2.1.3 Legal Requirements and Framework in Asia-Pacific
1.2.1.3.1 Japan
1.2.1.3.2 China
1.2.1.3.3 India
1.2.1.3.4 Taiwan
1.2.2 Patent Analysis
1.2.2.1 Patent Filing Trend (by Country)
1.2.2.2 Patent Filing Trend (by Year)
1.2.3 Funding Scenario
1.3 Market Dynamics
1.3.1 Overview
1.3.2 Market Drivers
1.3.2.1 Rapid Technological Advancements in Rare Disease Diagnosis
1.3.2.2 Rising Prevalence of Genetic Disorders and Congenital Disorders
1.3.2.3 Growing Recognition and Emphasis on Early Detection and Prevention of Rare Diseases in Pediatric Populations
1.3.3 Market Challenges
1.3.3.1 Lack of Consolidation of Information Leading to Difficulty in Diagnosis
1.3.3.2 Significant Capital Requirement for Research and Development Hindering Global Expansion Efforts
1.3.4 Market Opportunities
1.3.4.1 Whole Genome Sequencing Putting an End to the Rare Disease Genetic Testing Odysseys
1.3.4.2 AI-Based Diagnostic Tools Diagnosing Rare Diseases by Identifying Potential Diagnoses
1.3.4.3 Transitioning toward Increased Genetics Coverage in Reimbursement Policies
2 COMPETITIVE INSIGHTS
2.1 Competitive Benchmarking
2.1.1 Key Strategies and Developments
2.1.1.1 Funding Activities
2.1.1.2 New Offerings, Product Upgradation, and Approvals
2.1.1.3 Mergers and Acquisitions
2.1.1.4 Partnerships, Collaborations, And Business Expansion
2.1.2 Market Share Analysis
2.1.2.1 Rare Disease Genetic Testing Market, Market Share Analysis of Companies Offering Products
2.1.2.2 Rare Disease Genetic Testing Market, Market Share Analysis of Companies Offering Services.
2.1.3 Growth-Share Analysis
2.1.3.1 By Disease Type
2.1.3.2 By Technology Type
3 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY DISEASE TYPE), 2022-2033
3.1 Overview
3.2 Gastroenterology Disease
3.3 Endocrine and Metabolism Disease
3.4 Cardiovascular Disease
3.5 Neurology Disease
3.6 Hematology and Oncology Disease
3.7 Dermatology Disease
3.8 Other Diseases
4 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY OFFERING), 2022-2033
4.1 Overview
4.2 Products
4.3 Services
5 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY SPECIALTY TYPE), 2022-2033
5.1 Overview
5.2 Molecular Genetic Tests
5.3 Chromosomal Genetic Tests
5.4 Biochemical Genetic Tests
6 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY SAMPLE TYPE), 2022-2033
6.1 Overview
6.2 DNA Sample
6.3 Buccal Swab Sample
6.4 Blood Sample
6.5 Saliva Sample
6.6 Others
7 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY TRAIT TYPE), 2022-2033
7.1 Overview
7.2 Inherited Trait
7.3 Acquired Trait
8 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY TECHNOLOGY), 2022-2033
8.1 Overview
8.2 Polymerase Chain Reaction (PCR)
8.3 Next-Generation Sequencing (NGS)
8.3.1 Whole Genome Sequencing
8.3.2 Whole Exome Sequencing
8.4 Microarrays
8.5 Sanger Sequencing
8.6 Other Technologies
9 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY AGE GROUP), 2022-2033
9.1 Overview
9.2 Prenatal
9.3 Neonate and Infant
9.4 Children and Adolescent
9.5 Adult
10 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY END USER), 2022-2033
10.1 Overview
10.2 Hospitals
10.3 Diagnostic Laboratories
10.4 Other End User
11 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY REGION)
11.1 North America Rare Disease Genetic Testing Market
11.1.1 Market Dynamics
11.1.1.1 Impact Analysis
11.1.2 Market Sizing and Forecast
11.1.2.1 North America Rare Disease Genetic Testing Market (by Disease Type)
11.1.2.2 North America Rare Disease Genetic Testing Market (by Technology)
11.1.2.3 North America Rare Disease Genetic Testing Market (by Country)
11.1.2.3.1 U.S.
11.1.2.3.1.1 Market Dynamics
11.1.2.3.1.2 Market Size and Forecast
11.1.2.3.1.2.1 U.S. Rare Disease Genetic Testing Market (by Disease Type)
11.1.2.3.1.2.2 U.S. Rare Disease Genetic Testing Market (by Technology)
11.1.2.3.2 Canada
11.1.2.3.2.1 Market Dynamics
11.1.2.3.2.2 Market Size and Forecast
11.1.2.3.2.2.1 Canada Rare Disease Genetic Testing Market (by Disease Type)
11.1.2.3.2.2.2 Canada Rare Disease Genetic Testing Market (by Technology)
11.2 Europe Rare Disease Genetic Testing Market
11.2.1 Market Dynamics
11.2.1.1 Impact Analysis
11.2.2 Market Sizing and Forecast
11.2.2.1 Europe Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.2 Europe Rare Disease Genetic Testing Market (by Technology)
11.2.2.3 Europe Rare Disease Genetic Testing Market (by Country)
11.2.2.3.1 Germany
11.2.2.3.1.1 Market Dynamics
11.2.2.3.1.2 Market Size and Forecast
11.2.2.3.1.2.1 Germany Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.1.2.2 Germany Rare Disease Genetic Testing Market (by Technology)
11.2.2.3.2 U.K.
11.2.2.3.2.1 Market Dynamics
11.2.2.3.2.2 Market Size and Forecast
11.2.2.3.2.2.1 U.K Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.2.2.2 U.K. Rare Disease Genetic Testing Market (by Technology)
11.2.2.3.3 France
11.2.2.3.3.1 Market Dynamics
11.2.2.3.3.2 Market Size and Forecast
11.2.2.3.3.2.1 France Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.3.2.2 France Rare Disease Genetic Testing Market (by Technology)
11.2.2.3.4 Italy
11.2.2.3.4.1 Market Dynamics
11.2.2.3.4.2 Market Size and Forecast
11.2.2.3.4.2.1 Italy Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.4.2.2 Italy Rare Disease Genetic Testing Market (by Technology)
11.2.2.3.5 Spain
11.2.2.3.5.1 Market Dynamics
11.2.2.3.5.2 Market Size and Forecast
11.2.2.3.5.2.1 Spain Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.5.2.2 Spain Rare Disease Genetic Testing Market (by Technology)
11.2.2.3.6 Russia
11.2.2.3.6.1 Market Dynamics
11.2.2.3.6.2 Market Size and Forecast
11.2.2.3.6.2.1 Russia Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.6.2.2 Russia Rare Disease Genetic Testing Market (by Technology)
11.2.2.3.7 Rest-of-Europe
11.2.2.3.7.1 Market Dynamics
11.2.2.3.7.2 Market Size and Forecast
11.2.2.3.7.2.1 Rest-of-Europe Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.7.2.2 Rest-of-Europe Rare Disease Genetic Testing Market (by Technology)
11.3 Asia-Pacific Rare Disease Genetic Testing Market
11.3.1 Market Dynamics
11.3.1.1 Impact Analysis
11.3.2 Market Size and Forecast
11.3.2.1 Asia-Pacific Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.2 Asia-Pacific Rare Disease Genetic Testing Market (by Technology)
11.3.2.3 Asia-Pacific Rare Disease Genetic Testing Market (by Country)
11.3.2.3.1 Japan
11.3.2.3.1.1 Market Dynamics
11.3.2.3.1.2 Market Size and Forecast
11.3.2.3.1.2.1 Japan Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.1.2.2 Japan Rare Disease Genetic Testing Market (by Technology)
11.3.2.3.2 China
11.3.2.3.2.1 Market Dynamics
11.3.2.3.2.2 Market Size and Forecast
11.3.2.3.2.2.1 China Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.2.2.2 China Rare Disease Genetic Testing Market (by Technology)
11.3.2.3.3 Australia
11.3.2.3.3.1 Market Dynamics
11.3.2.3.3.2 Market Size and Forecast
11.3.2.3.3.2.1 Australia Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.3.2.2 Australia Rare Disease Genetic Testing Market (by Technology)
11.3.2.3.4 South Korea
11.3.2.3.4.1 Market Dynamics
11.3.2.3.4.2 Market Size and Forecast
11.3.2.3.4.2.1 South Korea Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.4.2.2 South Korea Rare Disease Genetic Testing Market (by Technology)
11.3.2.3.5 India
11.3.2.3.5.1 Market Dynamics
11.3.2.3.5.2 Market Size and Forecast
11.3.2.3.5.2.1 India Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.5.2.2 India Rare Disease Genetic Testing Market (by Technology)
11.3.2.3.6 Singapore
11.3.2.3.6.1 Market Dynamics
11.3.2.3.6.2 Market Size and Forecast
11.3.2.3.6.2.1 Singapore Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.6.2.2 Singapore Rare Disease Genetic Testing Market (by Technology)
11.3.2.3.7 Rest-of-Asia-Pacific
11.3.2.3.7.1 Market Dynamics
11.3.2.3.7.2 Market Size and Forecast
11.3.2.3.7.2.1 Rest-of-Asia-Pacific Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.7.2.2 Rest-of-Asia-Pacific Rare Disease Genetic Testing Market (by Technology)
11.4 Latin America Rare Disease Genetic Testing Market
11.4.1 Market Dynamics
11.4.1.1 Impact Analysis
11.4.2 Market Size and Forecast
11.4.2.1 Latin America Rare Disease Genetic Testing Market (by Disease Type)
11.4.2.2 Latin America Rare Disease Genetic Testing Market (by Technology)
11.4.2.3 Latin America Rare Disease Genetic Testing Market (by Country)
11.4.2.3.1 Brazil
11.4.2.3.1.1 Market Dynamics
11.4.2.3.1.2 Market Size and Forecast
11.4.2.3.1.2.1 Brazil Rare Disease Genetic Testing Market (by Disease Type)
11.4.2.3.1.2.2 Brazil Rare Disease Genetic Testing Market (by Technology)
11.4.2.3.2 Mexico
11.4.2.3.2.1 Market Dynamics
11.4.2.3.2.2 Market Size and Forecast
11.4.2.3.2.2.1 Mexico Rare Disease Genetic Testing Market (by Disease Type)
11.4.2.3.2.2.2 Mexico Rare Disease Genetic Testing Market (by Technology)
11.4.2.3.3 Rest-of-Latin America
11.4.2.3.3.1 Market Dynamics
11.4.2.3.3.2 Market Size and Forecast
11.4.2.3.3.2.1 Rest-of-Latin America Rare Disease Genetic Testing Market (by Disease Type)
11.4.2.3.3.2.2 Rest-of-Latin America Rare Disease Genetic Testing Market (by Technology)
11.5 Rest-of-the-World Rare Disease Genetic Testing Market
11.5.1 Market Dynamics
11.5.1.1 Impact Analysis
11.5.2 Market Size and Forecast
11.5.2.1 Rest-of-the-World Rare Disease Genetic Testing Market (by Disease Type)
11.5.2.2 Rest-of-the-World Rare Disease Genetic Testing Market (by Technology)
12 COMPANY PROFILES
12.1 Overview
12.1.1 23andMe Holding Co.
12.1.1.1 Company Overview
12.1.1.2 Role of 23andMe Holding Co. in the Global Rare Disease Genetic Testing Market
12.1.1.3 Financials
12.1.1.4 Recent Developments
12.1.1.5 Analyst Perspective
12.1.2 3billion, Inc.
12.1.2.1 Company Overview
12.1.2.2 Role of 3billion, Inc. in the Global Rare Disease Genetic Testing Market
12.1.2.3 Recent Developments
12.1.2.4 Analyst Perspective
12.1.3 Agilent Technologies, Inc.
12.1.3.1 Company Overview
12.1.3.2 Role of Agilent Technologies, Inc. in the Global Rare Disease Genetic Testing Market
12.1.3.3 Financials
12.1.3.4 Recent Developments
12.1.3.5 Analyst Perspective
12.1.4 Konica Minolta (Ambry Genetics, Inc.)
12.1.4.1 Company Overview
12.1.4.2 Role of Konica Minolta (Ambry Genetics, Inc.) in the Global Rare Disease Genetic Testing Market
12.1.4.3 Financials
12.1.4.4 Recent Developments
12.1.4.5 Analyst Perspective
12.1.5 BGI Group
12.1.5.1 Company Overview
12.1.5.2 Role of BGI Group in the Global Rare Disease Genetic Testing Market
12.1.5.3 Financials
12.1.5.4 Recent Developments
12.1.5.5 Analyst Perspective
12.1.6 CENTOGENE N.V.
12.1.6.1 Company Overview
12.1.6.2 Role of CENTOGENE N.V. in the Global Rare Disease Genetic Testing Market
12.1.6.3 Financials
12.1.6.4 Recent Developments
12.1.6.5 Analyst Perspective
12.1.7 Eurofins Scientific SE
12.1.7.1 Company Overview
12.1.7.2 Role of Eurofins Scientific SE in the Global Rare Disease Genetic Testing Market
12.1.7.3 Financials
12.1.7.4 Recent Developments
12.1.7.5 Analyst Perspective
12.1.8 GeneDx, Holdings Corp.
12.1.8.1 Company Overview
12.1.8.2 Role of GeneDx, Holdings Corp. in the Global Rare Disease Genetic Testing Market
12.1.8.3 Financials
12.1.8.4 Recent Developments
12.1.8.5 Analyst Perspective
12.1.9 Azenta U.S., Inc. (GENEWIZ, Inc.)
12.1.9.1 Company Overview
12.1.9.2 Role of Azenta U.S., Inc. (GENEWIZ, Inc.) in the Global Rare Disease Genetic Testing Market
12.1.9.3 Financials
12.1.9.4 Recent Developments
12.1.9.5 Analyst Perspective
12.1.10 Illumina, Inc.
12.1.10.1 Company Overview
12.1.10.2 Role of Illumina, Inc. in the Global Rare Disease Genetic Testing Market
12.1.10.3 Financials
12.1.10.4 Recent Developments
12.1.10.5 Analyst Perspective
12.1.11 Invitae Corporation
12.1.11.1 Company Overview
12.1.11.2 Role of Invitae Corporation in the Global Rare Disease Genetic Testing Market
12.1.11.3 Financials
12.1.11.4 Recent Developments
12.1.11.5 Analyst Perspective
12.1.12 Laboratory Corporation of America Holdings
12.1.12.1 Company Overview
12.1.12.2 Role of Laboratory Corporation of America Holdings in the Global Rare Disease Genetic Testing Market
12.1.12.3 Financials
12.1.12.4 Recent Developments
12.1.12.5 Analyst Perspective
12.1.13 Medgenome
12.1.13.1 Company Overview
12.1.13.2 Role of Medgenome in the Global Rare Disease Genetic Testing Market
12.1.13.3 Recent Developments
12.1.13.4 Analyst Perspective
12.1.14 Myriad Genetics, Inc.
12.1.14.1 Company Overview
12.1.14.2 Role of Myriad Genetics, Inc. in the Global Rare Disease Genetic Testing Market
12.1.14.3 Financials
12.1.14.4 Recent Developments
12.1.14.5 Analyst Perspective
12.1.15 OPKO Health, Inc.
12.1.15.1 Company Overview
12.1.15.2 Role of OPKO Health, Inc. in the Global Rare Disease Genetic Testing Market
12.1.15.3 Financials
12.1.15.4 Recent Developments
12.1.15.5 Analyst Perspective
12.1.16 PerkinElmer, Inc.
12.1.16.1 Company Overview
12.1.16.2 Role of PerkinElmer, Inc. in the Global Rare Disease Genetic Testing Market
12.1.16.3 Financials
12.1.16.4 Key Insights about the Financial Health of the Company
12.1.16.5 Recent Developments
12.1.16.6 Analyst Perspective
12.1.17 Exact Sciences Corporation (Prevention Genetics)
12.1.17.1 Company Overview
12.1.17.2 Role of Exact Sciences Corporation (Prevention Genetics) in the Global Rare Disease Genetic Testing Market
12.1.17.3 Financials
12.1.17.4 Recent Developments
12.1.17.5 Analyst Perspective
12.1.18 QIAGEN N.V.
12.1.18.1 Company Overview
12.1.18.2 Role of QIAGEN N.V. in the Global Rare Disease Genetic Testing Market
12.1.18.3 Financials
12.1.18.4 Recent Developments
12.1.18.5 Analyst Perspective
12.1.19 Quest Diagnostics Incorporated
12.1.19.1 Company Overview
12.1.19.2 Role of Quest Diagnostics Incorporated in the Global Rare Disease Genetic Testing Market
12.1.19.3 Financials
12.1.19.4 Analyst Perspective
12.1.20 Strand Life Science Pvt Ltd.
12.1.20.1 Company Overview
12.1.20.2 Role of Strand Life Science Pvt Ltd. in the Global Rare Disease Genetic Testing Market
12.1.20.3 Recent Developments
12.1.20.4 Analyst Perspective
1.1 Global Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.2.1 Inclusion Criteria
1.1.2.2 Exclusion Criteria
1.1.3 Market Overview
1.1.3.1 Market Footprint
1.1.3.2 Market Size and Future Growth Potential
1.1.4 COVID-19 Impact on the Market
1.1.4.1 Impact on Research and Clinical Operations
1.1.4.2 COVID-19 Impact: Current Scenario of the Market
1.2 Industry Analysis
1.2.1 Regulatory Framework
1.2.1.1 Legal Requirements and Framework in the U.S.
1.2.1.2 Legal Requirements and Framework in Europe
1.2.1.2.1 U.K.
1.2.1.2.2 Spain
1.2.1.3 Legal Requirements and Framework in Asia-Pacific
1.2.1.3.1 Japan
1.2.1.3.2 China
1.2.1.3.3 India
1.2.1.3.4 Taiwan
1.2.2 Patent Analysis
1.2.2.1 Patent Filing Trend (by Country)
1.2.2.2 Patent Filing Trend (by Year)
1.2.3 Funding Scenario
1.3 Market Dynamics
1.3.1 Overview
1.3.2 Market Drivers
1.3.2.1 Rapid Technological Advancements in Rare Disease Diagnosis
1.3.2.2 Rising Prevalence of Genetic Disorders and Congenital Disorders
1.3.2.3 Growing Recognition and Emphasis on Early Detection and Prevention of Rare Diseases in Pediatric Populations
1.3.3 Market Challenges
1.3.3.1 Lack of Consolidation of Information Leading to Difficulty in Diagnosis
1.3.3.2 Significant Capital Requirement for Research and Development Hindering Global Expansion Efforts
1.3.4 Market Opportunities
1.3.4.1 Whole Genome Sequencing Putting an End to the Rare Disease Genetic Testing Odysseys
1.3.4.2 AI-Based Diagnostic Tools Diagnosing Rare Diseases by Identifying Potential Diagnoses
1.3.4.3 Transitioning toward Increased Genetics Coverage in Reimbursement Policies
2 COMPETITIVE INSIGHTS
2.1 Competitive Benchmarking
2.1.1 Key Strategies and Developments
2.1.1.1 Funding Activities
2.1.1.2 New Offerings, Product Upgradation, and Approvals
2.1.1.3 Mergers and Acquisitions
2.1.1.4 Partnerships, Collaborations, And Business Expansion
2.1.2 Market Share Analysis
2.1.2.1 Rare Disease Genetic Testing Market, Market Share Analysis of Companies Offering Products
2.1.2.2 Rare Disease Genetic Testing Market, Market Share Analysis of Companies Offering Services.
2.1.3 Growth-Share Analysis
2.1.3.1 By Disease Type
2.1.3.2 By Technology Type
3 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY DISEASE TYPE), 2022-2033
3.1 Overview
3.2 Gastroenterology Disease
3.3 Endocrine and Metabolism Disease
3.4 Cardiovascular Disease
3.5 Neurology Disease
3.6 Hematology and Oncology Disease
3.7 Dermatology Disease
3.8 Other Diseases
4 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY OFFERING), 2022-2033
4.1 Overview
4.2 Products
4.3 Services
5 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY SPECIALTY TYPE), 2022-2033
5.1 Overview
5.2 Molecular Genetic Tests
5.3 Chromosomal Genetic Tests
5.4 Biochemical Genetic Tests
6 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY SAMPLE TYPE), 2022-2033
6.1 Overview
6.2 DNA Sample
6.3 Buccal Swab Sample
6.4 Blood Sample
6.5 Saliva Sample
6.6 Others
7 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY TRAIT TYPE), 2022-2033
7.1 Overview
7.2 Inherited Trait
7.3 Acquired Trait
8 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY TECHNOLOGY), 2022-2033
8.1 Overview
8.2 Polymerase Chain Reaction (PCR)
8.3 Next-Generation Sequencing (NGS)
8.3.1 Whole Genome Sequencing
8.3.2 Whole Exome Sequencing
8.4 Microarrays
8.5 Sanger Sequencing
8.6 Other Technologies
9 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY AGE GROUP), 2022-2033
9.1 Overview
9.2 Prenatal
9.3 Neonate and Infant
9.4 Children and Adolescent
9.5 Adult
10 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY END USER), 2022-2033
10.1 Overview
10.2 Hospitals
10.3 Diagnostic Laboratories
10.4 Other End User
11 GLOBAL RARE DISEASE GENETIC TESTING MARKET (BY REGION)
11.1 North America Rare Disease Genetic Testing Market
11.1.1 Market Dynamics
11.1.1.1 Impact Analysis
11.1.2 Market Sizing and Forecast
11.1.2.1 North America Rare Disease Genetic Testing Market (by Disease Type)
11.1.2.2 North America Rare Disease Genetic Testing Market (by Technology)
11.1.2.3 North America Rare Disease Genetic Testing Market (by Country)
11.1.2.3.1 U.S.
11.1.2.3.1.1 Market Dynamics
11.1.2.3.1.2 Market Size and Forecast
11.1.2.3.1.2.1 U.S. Rare Disease Genetic Testing Market (by Disease Type)
11.1.2.3.1.2.2 U.S. Rare Disease Genetic Testing Market (by Technology)
11.1.2.3.2 Canada
11.1.2.3.2.1 Market Dynamics
11.1.2.3.2.2 Market Size and Forecast
11.1.2.3.2.2.1 Canada Rare Disease Genetic Testing Market (by Disease Type)
11.1.2.3.2.2.2 Canada Rare Disease Genetic Testing Market (by Technology)
11.2 Europe Rare Disease Genetic Testing Market
11.2.1 Market Dynamics
11.2.1.1 Impact Analysis
11.2.2 Market Sizing and Forecast
11.2.2.1 Europe Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.2 Europe Rare Disease Genetic Testing Market (by Technology)
11.2.2.3 Europe Rare Disease Genetic Testing Market (by Country)
11.2.2.3.1 Germany
11.2.2.3.1.1 Market Dynamics
11.2.2.3.1.2 Market Size and Forecast
11.2.2.3.1.2.1 Germany Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.1.2.2 Germany Rare Disease Genetic Testing Market (by Technology)
11.2.2.3.2 U.K.
11.2.2.3.2.1 Market Dynamics
11.2.2.3.2.2 Market Size and Forecast
11.2.2.3.2.2.1 U.K Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.2.2.2 U.K. Rare Disease Genetic Testing Market (by Technology)
11.2.2.3.3 France
11.2.2.3.3.1 Market Dynamics
11.2.2.3.3.2 Market Size and Forecast
11.2.2.3.3.2.1 France Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.3.2.2 France Rare Disease Genetic Testing Market (by Technology)
11.2.2.3.4 Italy
11.2.2.3.4.1 Market Dynamics
11.2.2.3.4.2 Market Size and Forecast
11.2.2.3.4.2.1 Italy Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.4.2.2 Italy Rare Disease Genetic Testing Market (by Technology)
11.2.2.3.5 Spain
11.2.2.3.5.1 Market Dynamics
11.2.2.3.5.2 Market Size and Forecast
11.2.2.3.5.2.1 Spain Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.5.2.2 Spain Rare Disease Genetic Testing Market (by Technology)
11.2.2.3.6 Russia
11.2.2.3.6.1 Market Dynamics
11.2.2.3.6.2 Market Size and Forecast
11.2.2.3.6.2.1 Russia Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.6.2.2 Russia Rare Disease Genetic Testing Market (by Technology)
11.2.2.3.7 Rest-of-Europe
11.2.2.3.7.1 Market Dynamics
11.2.2.3.7.2 Market Size and Forecast
11.2.2.3.7.2.1 Rest-of-Europe Rare Disease Genetic Testing Market (by Disease Type)
11.2.2.3.7.2.2 Rest-of-Europe Rare Disease Genetic Testing Market (by Technology)
11.3 Asia-Pacific Rare Disease Genetic Testing Market
11.3.1 Market Dynamics
11.3.1.1 Impact Analysis
11.3.2 Market Size and Forecast
11.3.2.1 Asia-Pacific Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.2 Asia-Pacific Rare Disease Genetic Testing Market (by Technology)
11.3.2.3 Asia-Pacific Rare Disease Genetic Testing Market (by Country)
11.3.2.3.1 Japan
11.3.2.3.1.1 Market Dynamics
11.3.2.3.1.2 Market Size and Forecast
11.3.2.3.1.2.1 Japan Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.1.2.2 Japan Rare Disease Genetic Testing Market (by Technology)
11.3.2.3.2 China
11.3.2.3.2.1 Market Dynamics
11.3.2.3.2.2 Market Size and Forecast
11.3.2.3.2.2.1 China Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.2.2.2 China Rare Disease Genetic Testing Market (by Technology)
11.3.2.3.3 Australia
11.3.2.3.3.1 Market Dynamics
11.3.2.3.3.2 Market Size and Forecast
11.3.2.3.3.2.1 Australia Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.3.2.2 Australia Rare Disease Genetic Testing Market (by Technology)
11.3.2.3.4 South Korea
11.3.2.3.4.1 Market Dynamics
11.3.2.3.4.2 Market Size and Forecast
11.3.2.3.4.2.1 South Korea Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.4.2.2 South Korea Rare Disease Genetic Testing Market (by Technology)
11.3.2.3.5 India
11.3.2.3.5.1 Market Dynamics
11.3.2.3.5.2 Market Size and Forecast
11.3.2.3.5.2.1 India Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.5.2.2 India Rare Disease Genetic Testing Market (by Technology)
11.3.2.3.6 Singapore
11.3.2.3.6.1 Market Dynamics
11.3.2.3.6.2 Market Size and Forecast
11.3.2.3.6.2.1 Singapore Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.6.2.2 Singapore Rare Disease Genetic Testing Market (by Technology)
11.3.2.3.7 Rest-of-Asia-Pacific
11.3.2.3.7.1 Market Dynamics
11.3.2.3.7.2 Market Size and Forecast
11.3.2.3.7.2.1 Rest-of-Asia-Pacific Rare Disease Genetic Testing Market (by Disease Type)
11.3.2.3.7.2.2 Rest-of-Asia-Pacific Rare Disease Genetic Testing Market (by Technology)
11.4 Latin America Rare Disease Genetic Testing Market
11.4.1 Market Dynamics
11.4.1.1 Impact Analysis
11.4.2 Market Size and Forecast
11.4.2.1 Latin America Rare Disease Genetic Testing Market (by Disease Type)
11.4.2.2 Latin America Rare Disease Genetic Testing Market (by Technology)
11.4.2.3 Latin America Rare Disease Genetic Testing Market (by Country)
11.4.2.3.1 Brazil
11.4.2.3.1.1 Market Dynamics
11.4.2.3.1.2 Market Size and Forecast
11.4.2.3.1.2.1 Brazil Rare Disease Genetic Testing Market (by Disease Type)
11.4.2.3.1.2.2 Brazil Rare Disease Genetic Testing Market (by Technology)
11.4.2.3.2 Mexico
11.4.2.3.2.1 Market Dynamics
11.4.2.3.2.2 Market Size and Forecast
11.4.2.3.2.2.1 Mexico Rare Disease Genetic Testing Market (by Disease Type)
11.4.2.3.2.2.2 Mexico Rare Disease Genetic Testing Market (by Technology)
11.4.2.3.3 Rest-of-Latin America
11.4.2.3.3.1 Market Dynamics
11.4.2.3.3.2 Market Size and Forecast
11.4.2.3.3.2.1 Rest-of-Latin America Rare Disease Genetic Testing Market (by Disease Type)
11.4.2.3.3.2.2 Rest-of-Latin America Rare Disease Genetic Testing Market (by Technology)
11.5 Rest-of-the-World Rare Disease Genetic Testing Market
11.5.1 Market Dynamics
11.5.1.1 Impact Analysis
11.5.2 Market Size and Forecast
11.5.2.1 Rest-of-the-World Rare Disease Genetic Testing Market (by Disease Type)
11.5.2.2 Rest-of-the-World Rare Disease Genetic Testing Market (by Technology)
12 COMPANY PROFILES
12.1 Overview
12.1.1 23andMe Holding Co.
12.1.1.1 Company Overview
12.1.1.2 Role of 23andMe Holding Co. in the Global Rare Disease Genetic Testing Market
12.1.1.3 Financials
12.1.1.4 Recent Developments
12.1.1.5 Analyst Perspective
12.1.2 3billion, Inc.
12.1.2.1 Company Overview
12.1.2.2 Role of 3billion, Inc. in the Global Rare Disease Genetic Testing Market
12.1.2.3 Recent Developments
12.1.2.4 Analyst Perspective
12.1.3 Agilent Technologies, Inc.
12.1.3.1 Company Overview
12.1.3.2 Role of Agilent Technologies, Inc. in the Global Rare Disease Genetic Testing Market
12.1.3.3 Financials
12.1.3.4 Recent Developments
12.1.3.5 Analyst Perspective
12.1.4 Konica Minolta (Ambry Genetics, Inc.)
12.1.4.1 Company Overview
12.1.4.2 Role of Konica Minolta (Ambry Genetics, Inc.) in the Global Rare Disease Genetic Testing Market
12.1.4.3 Financials
12.1.4.4 Recent Developments
12.1.4.5 Analyst Perspective
12.1.5 BGI Group
12.1.5.1 Company Overview
12.1.5.2 Role of BGI Group in the Global Rare Disease Genetic Testing Market
12.1.5.3 Financials
12.1.5.4 Recent Developments
12.1.5.5 Analyst Perspective
12.1.6 CENTOGENE N.V.
12.1.6.1 Company Overview
12.1.6.2 Role of CENTOGENE N.V. in the Global Rare Disease Genetic Testing Market
12.1.6.3 Financials
12.1.6.4 Recent Developments
12.1.6.5 Analyst Perspective
12.1.7 Eurofins Scientific SE
12.1.7.1 Company Overview
12.1.7.2 Role of Eurofins Scientific SE in the Global Rare Disease Genetic Testing Market
12.1.7.3 Financials
12.1.7.4 Recent Developments
12.1.7.5 Analyst Perspective
12.1.8 GeneDx, Holdings Corp.
12.1.8.1 Company Overview
12.1.8.2 Role of GeneDx, Holdings Corp. in the Global Rare Disease Genetic Testing Market
12.1.8.3 Financials
12.1.8.4 Recent Developments
12.1.8.5 Analyst Perspective
12.1.9 Azenta U.S., Inc. (GENEWIZ, Inc.)
12.1.9.1 Company Overview
12.1.9.2 Role of Azenta U.S., Inc. (GENEWIZ, Inc.) in the Global Rare Disease Genetic Testing Market
12.1.9.3 Financials
12.1.9.4 Recent Developments
12.1.9.5 Analyst Perspective
12.1.10 Illumina, Inc.
12.1.10.1 Company Overview
12.1.10.2 Role of Illumina, Inc. in the Global Rare Disease Genetic Testing Market
12.1.10.3 Financials
12.1.10.4 Recent Developments
12.1.10.5 Analyst Perspective
12.1.11 Invitae Corporation
12.1.11.1 Company Overview
12.1.11.2 Role of Invitae Corporation in the Global Rare Disease Genetic Testing Market
12.1.11.3 Financials
12.1.11.4 Recent Developments
12.1.11.5 Analyst Perspective
12.1.12 Laboratory Corporation of America Holdings
12.1.12.1 Company Overview
12.1.12.2 Role of Laboratory Corporation of America Holdings in the Global Rare Disease Genetic Testing Market
12.1.12.3 Financials
12.1.12.4 Recent Developments
12.1.12.5 Analyst Perspective
12.1.13 Medgenome
12.1.13.1 Company Overview
12.1.13.2 Role of Medgenome in the Global Rare Disease Genetic Testing Market
12.1.13.3 Recent Developments
12.1.13.4 Analyst Perspective
12.1.14 Myriad Genetics, Inc.
12.1.14.1 Company Overview
12.1.14.2 Role of Myriad Genetics, Inc. in the Global Rare Disease Genetic Testing Market
12.1.14.3 Financials
12.1.14.4 Recent Developments
12.1.14.5 Analyst Perspective
12.1.15 OPKO Health, Inc.
12.1.15.1 Company Overview
12.1.15.2 Role of OPKO Health, Inc. in the Global Rare Disease Genetic Testing Market
12.1.15.3 Financials
12.1.15.4 Recent Developments
12.1.15.5 Analyst Perspective
12.1.16 PerkinElmer, Inc.
12.1.16.1 Company Overview
12.1.16.2 Role of PerkinElmer, Inc. in the Global Rare Disease Genetic Testing Market
12.1.16.3 Financials
12.1.16.4 Key Insights about the Financial Health of the Company
12.1.16.5 Recent Developments
12.1.16.6 Analyst Perspective
12.1.17 Exact Sciences Corporation (Prevention Genetics)
12.1.17.1 Company Overview
12.1.17.2 Role of Exact Sciences Corporation (Prevention Genetics) in the Global Rare Disease Genetic Testing Market
12.1.17.3 Financials
12.1.17.4 Recent Developments
12.1.17.5 Analyst Perspective
12.1.18 QIAGEN N.V.
12.1.18.1 Company Overview
12.1.18.2 Role of QIAGEN N.V. in the Global Rare Disease Genetic Testing Market
12.1.18.3 Financials
12.1.18.4 Recent Developments
12.1.18.5 Analyst Perspective
12.1.19 Quest Diagnostics Incorporated
12.1.19.1 Company Overview
12.1.19.2 Role of Quest Diagnostics Incorporated in the Global Rare Disease Genetic Testing Market
12.1.19.3 Financials
12.1.19.4 Analyst Perspective
12.1.20 Strand Life Science Pvt Ltd.
12.1.20.1 Company Overview
12.1.20.2 Role of Strand Life Science Pvt Ltd. in the Global Rare Disease Genetic Testing Market
12.1.20.3 Recent Developments
12.1.20.4 Analyst Perspective
LIST OF FIGURES
Figure 1: Global Prevalence Rare Disease, 2022
Figure 2: Global Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 3: Global Rare Disease Genetic Testing Market, Market Dynamics
Figure 4: Most Frequently Studied Rare Diseases, 2021
Figure 5: Global Rare Disease Genetic Testing Market Share (by Technology), 2022 and 2033
Figure 6: Global Rare Disease Genetic Testing Market Share (by Specialty Type), 2022 and 2033
Figure 7: Global Rare Disease Genetic Testing Market Share (by Offering), 2022 and 2033
Figure 8: Global Rare Disease Genetic Testing Market Share (by Disease Type), 2022 and 2033
Figure 9: Global Rare Disease Genetic Testing Market Share (by Sample Type), 2022 and 2033
Figure 10: Global Rare Disease Genetic Testing Market Share (by Trait Type), 2022 and 2033
Figure 11: Global Rare Disease Genetic Testing Market Share (by End User), 2022 and 2033
Figure 12: Global Rare Disease Genetic Testing Market (by Region), $Billion, 2022 and 2033
Figure 13: Share of Key Developments and Strategies, January 2019-June 2023
Figure 14: Global Rare Disease Genetic Testing Market Segmentation
Figure 15: Global Rare Disease Genetic Testing Market: Research Methodology
Figure 16: Primary Research Methodology
Figure 17: Bottom-Up Approach (Segment-Wise Analysis)
Figure 18: Top-Down Approach (Segment-Wise Analysis)
Figure 19: Global Rare Disease Genetic Testing Market Potential, $Billion, 2022-2033
Figure 20: Regulatory Scenario in Europe (by Country)
Figure 21: Global Rare Disease Genetic Testing Market, Patent Analysis (by Country), January 2018- June 2023
Figure 22: Global Rare Disease Genetic Testing Market, Patent Analysis (by Year), January 2018-June 2023
Figure 23: NIH Funding on Rare Diseases, $Million, 2013-2023
Figure 24: Global Rare Disease Genetic Testing Market Dynamics
Figure 25: Rare Disease Prevalence in India, 2022
Figure 26: Global Prevalence of Rare Diseases, 2022
Figure 27: Most Frequently Studied Rare Diseases, 2021
Figure 28: Publications Related to the Use of Artificial Intelligence for Rare Disease Diagnosis, 2015-2022
Figure 29: Global Rare Disease Genetic Testing Market, Number of Key Developments and Strategies, January 2019-June 2023
Figure 30: Global Rare Disease Genetic Testing Market, Number of Funding Activities, January 2019-June 2023
Figure 31: Global Rare Disease Genetic Testing Market, Number of New Offerings, Product Upgradation, and Approvals January 2019-June 2023
Figure 32: Global Rare Disease Genetic Testing Market, Number of Mergers and Acquisitions, January 2019-June 2023
Figure 33: Global Rare Disease Genetic Testing Market, Number of Partnerships, Collaborations, and Business Expansions, January 2019-June 2023
Figure 34: Global Rare Disease Genetic Testing Market, Company Revenue Share Analysis of Companies Offering Products, $Billion, 2022
Figure 35: Global Rare Disease Genetic Testing Market, Company Revenue Share Analysis of Companies Offering Services, $Billion, 2022
Figure 36: Global Rare Disease Genetic Testing Market, Growth-Share Matrix (by Disease Type), 2023-2033
Figure 37: Global Rare Disease Genetic Testing Market, Growth-Share Matrix (by Technology Type), 2023-2033
Figure 38: Global Rare Disease Genetic Testing Market (by Disease Type)
Figure 39: Global Rare Disease Genetic Testing Market (by Disease Type), $Billion, 2022-2032
Figure 40: Global Rare Disease Genetic Testing Market (Gastroenterology Disease), $Billion, 2022-2033
Figure 41: Global Rare Disease Genetic Testing Market (Endocrine and Metabolism Disease), $Billion, 2022-2033
Figure 42: Global Rare Disease Genetic Testing Market (Cardiovascular Disease), $Billion, 2022-2033
Figure 43: Global Rare Disease Genetic Testing Market (Neurology Disease), $Billion, 2022-2033
Figure 44: Global Rare Disease Genetic Testing Market (Hematology and Oncology Disease), $Billion, 2022-2033
Figure 45: Global Rare Disease Genetic Testing Market (Dermatology Disease), $Billion, 2022-2033
Figure 46: Global Rare Disease Genetic Testing Market (Other Diseases), $Billion, 2022-2033
Figure 47: Global Rare Disease Genetic Testing Market (by Offering)
Figure 48: Global Rare Disease Genetic Testing Market (by Offering), $Billion, 2022-2032
Figure 49: Global Rare Disease Genetic Testing Market (Products), $Billion, 2022-2033
Figure 50: Global Rare Disease Genetic Testing Market (Services), $Billion, 2022-2033
Figure 51: Global Rare Disease Genetic Testing Market (by Specialty Type)
Figure 52: Global Rare Disease Genetic Testing Market (by Specialty Type), $Billion, 2022-2032
Figure 53: Global Rare Disease Genetic Testing Market (Molecular Genetic Tests), $Billion, 2022-2033
Figure 54: Global Rare Disease Genetic Testing Market (Chromosomal Genetic Tests), $Billion, 2022-2033
Figure 55: Global Rare Disease Genetic Testing Market (Biochemical Genetic Tests), $Billion, 2022-2033
Figure 56: Global Rare Disease Genetic Testing Market (by Sample Type)
Figure 57: Global Rare Disease Genetic Testing Market (by Sample Type), $Billion, 2022-2032
Figure 58: Global Rare Disease Genetic Testing Market (DNA Sample), $Billion, 2022-2033
Figure 59: Global Rare Disease Genetic Testing Market (Buccal Swab Sample), $Billion, 2022-2033
Figure 60: Global Rare Disease Genetic Testing Market (Blood Sample), $Billion, 2022-2033
Figure 61: Global Rare Disease Genetic Testing Market (Saliva Sample), $Billion, 2022-2033
Figure 62: Global Rare Disease Genetic Testing Market (Others), $Billion, 2022-2033
Figure 63: Global Rare Disease Genetic Testing Market (by Trait Type)
Figure 64: Global Rare Disease Genetic Testing Market (by Trait Type), $Billion, 2022-2032
Figure 65: Global Rare Disease Genetic Testing Market (Inherited Trait), $Billion, 2022-2033
Figure 66: Global Rare Disease Genetic Testing Market (Acquired Trait), $Billion, 2022-2033
Figure 67: Global Rare Disease Genetic Testing Market (by Technology)
Figure 68: Global Rare Disease Genetic Testing Market (by Technology), $Billion, 2022-2032
Figure 69: Global Rare Disease Genetic Testing Market (Polymerase Chain Reaction (PCR)), $Billion, 2022-2033
Figure 70: Global Rare Disease Genetic Testing Market (by Next-Generation Sequencing (NGS)), $Billion, 2022-2033
Figure 71: Global Rare Disease Genetic Testing Market (Whole Genome Sequencing), $Billion, 2022-2033
Figure 72: Global Rare Disease Genetic Testing Market (Whole Exome Sequencing), $Billion, 2022-2033
Figure 73: Global Rare Disease Genetic Testing Market (Microarrays), $Billion, 2022-2033
Figure 74: Global Rare Disease Genetic Testing Market (Sanger Sequencing), $Billion, 2022-2033
Figure 75: Global Rare Disease Genetic Testing Market (Other Technologies), $Billion, 2022-2033
Figure 76: Global Rare Disease Genetic Testing Market (by Age Group)
Figure 77: Global Rare Disease Genetic Testing Market (by Age Group), $Billion, 2022-2032
Figure 78: Global Rare Disease Genetic Testing Market (Prenatal), $Billion, 2022-2033
Figure 79: Global Rare Disease Genetic Testing Market (Neonate and Infant), $Billion, 2022-2033
Figure 80: Global Rare Disease Genetic Testing Market (Children and Adolescent), $Billion, 2022-2033
Figure 81: Global Rare Disease Genetic Testing Market (Adult), $Billion, 2022-2033
Figure 82: Global Rare Disease Genetic Testing Market (by End User)
Figure 83: Global Rare Disease Genetic Testing Market (by End User), $Billion, 2022-2032
Figure 84: Global Rare Disease Genetic Testing Market (Hospitals), $Billion, 2022-2033
Figure 85: Global Rare Disease Genetic Testing Market (Diagnostic Laboratories), $Billion, 2022-2033
Figure 86: Global Rare Disease Genetic Testing Market (Other End User), $Billion, 2022-2033
Figure 87: Global Rare Disease Genetic Testing Market Share (by Region), 2022-2033
Figure 88: North America Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 89: North America Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 90: North America Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 91: North America Rare Disease Genetic Testing Market (by Country), % Share, 2022 and 2033
Figure 92: U.S. Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 93: U.S. Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 94: U.S. Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 95: Canada Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 96: Canada Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 97: Canada Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 98: Europe Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 99: Europe Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 100: Europe Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 101: Europe Rare Disease Genetic Testing Market (by Country), % Share, 2022 and 2033
Figure 102: Germany Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 103: Germany Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 104: Germany Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 105: U.K. Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 106: U.K. Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 107: U.K. Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 108: France Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 109: France Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 110: France Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 111: Italy Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 112: Italy Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 113: Italy Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 114: Spain Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 115: Spain Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 116: Spain Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 117: Russia Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 118: Russia Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 119: Russia Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 120: Rest-of-Europe Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 121: Rest-of-Europe Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 122: Rest-of-Europe Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 123: Asia-Pacific Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 124: Asia-Pacific Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 125: Asia-Pacific Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 126: Asia-Pacific Rare Disease Genetic Testing Market (by Country), % Share, 2022 and 2033
Figure 127: Japan Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 128: Japan Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 129: Japan Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 130: China Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 131: China Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 132: China Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 133: Australia Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 134: Australia Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 135: Australia Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 136: South Korea Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 137: South Korea Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 138: South Korea Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 139: India Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 140: India Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 141: India Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 142: Singapore Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 143: Singapore Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 144: Singapore Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 145: Rest-of-Asia-Pacific Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 146: Rest-of-Asia-Pacific Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 147: Rest-of-Asia-Pacific Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 148: Latin America Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 149: Latin America Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 150: Latin America Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 151: Latin America Rare Disease Genetic Testing Market (by Country), % Share, 2022 and 2033
Figure 152: Brazil Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 153: Brazil Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 154: Brazil Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 155: Mexico Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 156: Mexico Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 157: Mexico Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 158: Rest-of-Latin America Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 159: Rest-of-Latin America Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 160: Rest-of-Latin America Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 161: Rest-of-the-World Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 162: Rest-of-the-World Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 163: Rest-of-the-World Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 164: Global Rare Disease Genetic Testing Market, Total Number of Key Companies Profiled
Figure 165: 23andMe, Inc: Product Portfolio
Figure 166: 23andMe Holding Co.: Overall Financials, $Million, 2020-2022
Figure 167: 23andMe Holding Co.: Net Revenue (by Segment), $Million, 2020-2022
Figure 168: 23andMe Holding Co.: Net Revenue (by Region), $Million, 2020-2022
Figure 169: 23andMe Holding Co.: R&D Expenditure, $Million, 2020-2022
Figure 170: 3billion, Inc: Product Portfolio
Figure 171: Agilent Technologies, Inc: Product Portfolio
Figure 172: Agilent Technologies, Inc.: Overall Financials, $Million, 2020-2022
Figure 173: Agilent Technologies, Inc.: Net Revenue (by Segment), $Million, 2020-2022
Figure 174: Agilent Technologies, Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 175: Agilent Technologies, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 176: Konica Minolta (Ambry Genetics, Inc.): Product Portfolio
Figure 177: Konica Minolta (Ambry Genetics, Inc.).: Overall Financials, $Million, 2020-2022
Figure 178: Konica Minolta (Ambry Genetics, Inc.): Net Revenue (by Segment), $Million, 2020-2022
Figure 179: Konica Minolta (Ambry Genetics, Inc.): Net Revenue (by Region), $Million, 2020-2022
Figure 180: Konica Minolta (Ambry Genetics, Inc.): R&D Expenditure, $Million, 2020-2022
Figure 181: BGI Genomics: Product Portfolio
Figure 182: BGI Genomics.: Overall Financials, $Million, 2020-2022
Figure 183: CENTOGENE N.V.: Product Portfolio
Figure 184: CENTOGENE N.V.: Overall Financials, $Million, 2020-2022
Figure 185: CENTOGENE N.V.: Net Revenue (by Segment), $Million, 2020-2022
Figure 186: CENTOGENE N.V.: Net Revenue (by Region), $Million, 2020-2022
Figure 187: CENTOGENE N.V.: R&D Expenditure, $Million, 2020-202
Figure 188: Eurofins Scientific SE: Product Portfolio
Figure 189: Eurofins Scientific SE: Overall Financials, $Million, 2020-2022
Figure 190: Eurofins Scientific SE: Net Revenue (by Segment), $Million, 2020-2022
Figure 191: Eurofins Scientific SE: Net Revenue (by Region), $Million, 2020-2022
Figure 192: GeneDx, Holdings Corp.: Product Portfolio
Figure 193: GeneDx, Holdings Corp.: Overall Financials, $Million, 2020-2022
Figure 194: GeneDx, Holdings Corp.: Net Revenue (by Segment), $Million, 2020-2022
Figure 195: GeneDx, Holdings Corp.: R&D Expenditure, $Million, 2020-2022
Figure 196: Azenta U.S., Inc. (GENEWIZ, Inc.): Product Portfolio
Figure 197: Azenta U.S., Inc. (GENEWIZ, Inc.): Overall Financials, $Million, 2020-2022
Figure 198: Azenta U.S., Inc. (GENEWIZ, Inc.): Net Revenue (by Segment), $Million, 2020-2022
Figure 199: Azenta U.S., Inc. (GENEWIZ, Inc.): Net Revenue (by Region), $Million, 2020-2022
Figure 200: Illumina, Inc.: Product Portfolio
Figure 201: Illumina, Inc.: Overall Financials, $Million, 2020-2022
Figure 202: Illumina, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 203: Illumina, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 204: Illumina, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 205: Invitae Corporation: Product Portfolio
Figure 206: Invitae Corporation: Overall Financials, $Million, 2020-2022
Figure 207: Invitae Corporation: Net Revenue (by Segment), $Million, 2020-2022
Figure 208: Invitae Corporation: Net Revenue (by Region), $Million, 2020-2022
Figure 209: Laboratory Corporation of America Holdings: Product Portfolio
Figure 210: Laboratory Corporation of America Holdings: Overall Financials, $Million, 2020-2022
Figure 211: Laboratory Corporation of America Holdings: Revenue (by Segment), $Million, 2020-2022
Figure 212: Laboratory Corporation of America Holdings: Revenue (by Region), $Million, 2020-2022
Figure 213: Medgenome: Product Portfolio
Figure 214: Myriad Genetics, Inc.: Product Portfolio
Figure 215: Myriad Genetics, Inc.: Overall Financials, $Million, 2020-2022
Figure 216: Myriad Genetics, Inc.: Net Revenue (by Segment), $Million, 2020-2022
Figure 217: Myriad Genetics, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 218: OPKO Health, Inc.: Product Portfolio
Figure 219: OPKO Health, Inc.: Overall Financials, $Million, 2020-2022
Figure 220: OPKO Health, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 221: PerkinElmer, Inc.: Product Portfolio
Figure 222: PerkinElmer, Inc.: Overall Financials, $Million, 2020-2022
Figure 223: PerkinElmer, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 224: PerkinElmer, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 225: PerkinElmer, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 226: Exact Sciences Corporation (Prevention Genetics): Product Portfolio
Figure 227: Exact Sciences Corporation: Overall Financials, $Million, 2020-2022
Figure 228: Exact Sciences Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 229: Exact Sciences Corporation: Revenue (by Region), $Million, 2020-2022
Figure 230: Exact Sciences Corporation: R&D Expenditure, $Million, 2020-2022
Figure 231: QIAGEN N.V.: Product Portfolio
Figure 232: QIAGEN N.V.: Overall Financials, $Million, 2020-2022
Figure 233: QIAGEN N.V.: Revenue (by Segment), $Million, 2020-2022
Figure 234: QIAGEN N.V.: Revenue (by Region), $Million, 2020-2022
Figure 235: QIAGEN N.V.: R&D Expenditure, $Million, 2020-2022
Figure 236: Quest Diagnostics Incorporated.: Product Portfolio
Figure 237: Quest Diagnostics Incorporated: Overall Financials, $Million, 2020-2022
Figure 238: Quest Diagnostics Incorporated: Revenue (by Segment), $Million, 2020-2022
Figure 239: Strand Life Science Pvt Ltd.: Product Portfolio
Figure 1: Global Prevalence Rare Disease, 2022
Figure 2: Global Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 3: Global Rare Disease Genetic Testing Market, Market Dynamics
Figure 4: Most Frequently Studied Rare Diseases, 2021
Figure 5: Global Rare Disease Genetic Testing Market Share (by Technology), 2022 and 2033
Figure 6: Global Rare Disease Genetic Testing Market Share (by Specialty Type), 2022 and 2033
Figure 7: Global Rare Disease Genetic Testing Market Share (by Offering), 2022 and 2033
Figure 8: Global Rare Disease Genetic Testing Market Share (by Disease Type), 2022 and 2033
Figure 9: Global Rare Disease Genetic Testing Market Share (by Sample Type), 2022 and 2033
Figure 10: Global Rare Disease Genetic Testing Market Share (by Trait Type), 2022 and 2033
Figure 11: Global Rare Disease Genetic Testing Market Share (by End User), 2022 and 2033
Figure 12: Global Rare Disease Genetic Testing Market (by Region), $Billion, 2022 and 2033
Figure 13: Share of Key Developments and Strategies, January 2019-June 2023
Figure 14: Global Rare Disease Genetic Testing Market Segmentation
Figure 15: Global Rare Disease Genetic Testing Market: Research Methodology
Figure 16: Primary Research Methodology
Figure 17: Bottom-Up Approach (Segment-Wise Analysis)
Figure 18: Top-Down Approach (Segment-Wise Analysis)
Figure 19: Global Rare Disease Genetic Testing Market Potential, $Billion, 2022-2033
Figure 20: Regulatory Scenario in Europe (by Country)
Figure 21: Global Rare Disease Genetic Testing Market, Patent Analysis (by Country), January 2018- June 2023
Figure 22: Global Rare Disease Genetic Testing Market, Patent Analysis (by Year), January 2018-June 2023
Figure 23: NIH Funding on Rare Diseases, $Million, 2013-2023
Figure 24: Global Rare Disease Genetic Testing Market Dynamics
Figure 25: Rare Disease Prevalence in India, 2022
Figure 26: Global Prevalence of Rare Diseases, 2022
Figure 27: Most Frequently Studied Rare Diseases, 2021
Figure 28: Publications Related to the Use of Artificial Intelligence for Rare Disease Diagnosis, 2015-2022
Figure 29: Global Rare Disease Genetic Testing Market, Number of Key Developments and Strategies, January 2019-June 2023
Figure 30: Global Rare Disease Genetic Testing Market, Number of Funding Activities, January 2019-June 2023
Figure 31: Global Rare Disease Genetic Testing Market, Number of New Offerings, Product Upgradation, and Approvals January 2019-June 2023
Figure 32: Global Rare Disease Genetic Testing Market, Number of Mergers and Acquisitions, January 2019-June 2023
Figure 33: Global Rare Disease Genetic Testing Market, Number of Partnerships, Collaborations, and Business Expansions, January 2019-June 2023
Figure 34: Global Rare Disease Genetic Testing Market, Company Revenue Share Analysis of Companies Offering Products, $Billion, 2022
Figure 35: Global Rare Disease Genetic Testing Market, Company Revenue Share Analysis of Companies Offering Services, $Billion, 2022
Figure 36: Global Rare Disease Genetic Testing Market, Growth-Share Matrix (by Disease Type), 2023-2033
Figure 37: Global Rare Disease Genetic Testing Market, Growth-Share Matrix (by Technology Type), 2023-2033
Figure 38: Global Rare Disease Genetic Testing Market (by Disease Type)
Figure 39: Global Rare Disease Genetic Testing Market (by Disease Type), $Billion, 2022-2032
Figure 40: Global Rare Disease Genetic Testing Market (Gastroenterology Disease), $Billion, 2022-2033
Figure 41: Global Rare Disease Genetic Testing Market (Endocrine and Metabolism Disease), $Billion, 2022-2033
Figure 42: Global Rare Disease Genetic Testing Market (Cardiovascular Disease), $Billion, 2022-2033
Figure 43: Global Rare Disease Genetic Testing Market (Neurology Disease), $Billion, 2022-2033
Figure 44: Global Rare Disease Genetic Testing Market (Hematology and Oncology Disease), $Billion, 2022-2033
Figure 45: Global Rare Disease Genetic Testing Market (Dermatology Disease), $Billion, 2022-2033
Figure 46: Global Rare Disease Genetic Testing Market (Other Diseases), $Billion, 2022-2033
Figure 47: Global Rare Disease Genetic Testing Market (by Offering)
Figure 48: Global Rare Disease Genetic Testing Market (by Offering), $Billion, 2022-2032
Figure 49: Global Rare Disease Genetic Testing Market (Products), $Billion, 2022-2033
Figure 50: Global Rare Disease Genetic Testing Market (Services), $Billion, 2022-2033
Figure 51: Global Rare Disease Genetic Testing Market (by Specialty Type)
Figure 52: Global Rare Disease Genetic Testing Market (by Specialty Type), $Billion, 2022-2032
Figure 53: Global Rare Disease Genetic Testing Market (Molecular Genetic Tests), $Billion, 2022-2033
Figure 54: Global Rare Disease Genetic Testing Market (Chromosomal Genetic Tests), $Billion, 2022-2033
Figure 55: Global Rare Disease Genetic Testing Market (Biochemical Genetic Tests), $Billion, 2022-2033
Figure 56: Global Rare Disease Genetic Testing Market (by Sample Type)
Figure 57: Global Rare Disease Genetic Testing Market (by Sample Type), $Billion, 2022-2032
Figure 58: Global Rare Disease Genetic Testing Market (DNA Sample), $Billion, 2022-2033
Figure 59: Global Rare Disease Genetic Testing Market (Buccal Swab Sample), $Billion, 2022-2033
Figure 60: Global Rare Disease Genetic Testing Market (Blood Sample), $Billion, 2022-2033
Figure 61: Global Rare Disease Genetic Testing Market (Saliva Sample), $Billion, 2022-2033
Figure 62: Global Rare Disease Genetic Testing Market (Others), $Billion, 2022-2033
Figure 63: Global Rare Disease Genetic Testing Market (by Trait Type)
Figure 64: Global Rare Disease Genetic Testing Market (by Trait Type), $Billion, 2022-2032
Figure 65: Global Rare Disease Genetic Testing Market (Inherited Trait), $Billion, 2022-2033
Figure 66: Global Rare Disease Genetic Testing Market (Acquired Trait), $Billion, 2022-2033
Figure 67: Global Rare Disease Genetic Testing Market (by Technology)
Figure 68: Global Rare Disease Genetic Testing Market (by Technology), $Billion, 2022-2032
Figure 69: Global Rare Disease Genetic Testing Market (Polymerase Chain Reaction (PCR)), $Billion, 2022-2033
Figure 70: Global Rare Disease Genetic Testing Market (by Next-Generation Sequencing (NGS)), $Billion, 2022-2033
Figure 71: Global Rare Disease Genetic Testing Market (Whole Genome Sequencing), $Billion, 2022-2033
Figure 72: Global Rare Disease Genetic Testing Market (Whole Exome Sequencing), $Billion, 2022-2033
Figure 73: Global Rare Disease Genetic Testing Market (Microarrays), $Billion, 2022-2033
Figure 74: Global Rare Disease Genetic Testing Market (Sanger Sequencing), $Billion, 2022-2033
Figure 75: Global Rare Disease Genetic Testing Market (Other Technologies), $Billion, 2022-2033
Figure 76: Global Rare Disease Genetic Testing Market (by Age Group)
Figure 77: Global Rare Disease Genetic Testing Market (by Age Group), $Billion, 2022-2032
Figure 78: Global Rare Disease Genetic Testing Market (Prenatal), $Billion, 2022-2033
Figure 79: Global Rare Disease Genetic Testing Market (Neonate and Infant), $Billion, 2022-2033
Figure 80: Global Rare Disease Genetic Testing Market (Children and Adolescent), $Billion, 2022-2033
Figure 81: Global Rare Disease Genetic Testing Market (Adult), $Billion, 2022-2033
Figure 82: Global Rare Disease Genetic Testing Market (by End User)
Figure 83: Global Rare Disease Genetic Testing Market (by End User), $Billion, 2022-2032
Figure 84: Global Rare Disease Genetic Testing Market (Hospitals), $Billion, 2022-2033
Figure 85: Global Rare Disease Genetic Testing Market (Diagnostic Laboratories), $Billion, 2022-2033
Figure 86: Global Rare Disease Genetic Testing Market (Other End User), $Billion, 2022-2033
Figure 87: Global Rare Disease Genetic Testing Market Share (by Region), 2022-2033
Figure 88: North America Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 89: North America Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 90: North America Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 91: North America Rare Disease Genetic Testing Market (by Country), % Share, 2022 and 2033
Figure 92: U.S. Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 93: U.S. Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 94: U.S. Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 95: Canada Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 96: Canada Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 97: Canada Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 98: Europe Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 99: Europe Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 100: Europe Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 101: Europe Rare Disease Genetic Testing Market (by Country), % Share, 2022 and 2033
Figure 102: Germany Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 103: Germany Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 104: Germany Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 105: U.K. Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 106: U.K. Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 107: U.K. Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 108: France Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 109: France Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 110: France Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 111: Italy Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 112: Italy Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 113: Italy Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 114: Spain Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 115: Spain Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 116: Spain Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 117: Russia Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 118: Russia Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 119: Russia Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 120: Rest-of-Europe Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 121: Rest-of-Europe Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 122: Rest-of-Europe Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 123: Asia-Pacific Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 124: Asia-Pacific Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 125: Asia-Pacific Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 126: Asia-Pacific Rare Disease Genetic Testing Market (by Country), % Share, 2022 and 2033
Figure 127: Japan Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 128: Japan Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 129: Japan Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 130: China Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 131: China Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 132: China Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 133: Australia Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 134: Australia Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 135: Australia Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 136: South Korea Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 137: South Korea Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 138: South Korea Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 139: India Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 140: India Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 141: India Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 142: Singapore Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 143: Singapore Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 144: Singapore Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 145: Rest-of-Asia-Pacific Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 146: Rest-of-Asia-Pacific Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 147: Rest-of-Asia-Pacific Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 148: Latin America Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 149: Latin America Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 150: Latin America Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 151: Latin America Rare Disease Genetic Testing Market (by Country), % Share, 2022 and 2033
Figure 152: Brazil Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 153: Brazil Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 154: Brazil Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 155: Mexico Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 156: Mexico Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 157: Mexico Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 158: Rest-of-Latin America Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 159: Rest-of-Latin America Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 160: Rest-of-Latin America Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 161: Rest-of-the-World Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 162: Rest-of-the-World Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 163: Rest-of-the-World Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 164: Global Rare Disease Genetic Testing Market, Total Number of Key Companies Profiled
Figure 165: 23andMe, Inc: Product Portfolio
Figure 166: 23andMe Holding Co.: Overall Financials, $Million, 2020-2022
Figure 167: 23andMe Holding Co.: Net Revenue (by Segment), $Million, 2020-2022
Figure 168: 23andMe Holding Co.: Net Revenue (by Region), $Million, 2020-2022
Figure 169: 23andMe Holding Co.: R&D Expenditure, $Million, 2020-2022
Figure 170: 3billion, Inc: Product Portfolio
Figure 171: Agilent Technologies, Inc: Product Portfolio
Figure 172: Agilent Technologies, Inc.: Overall Financials, $Million, 2020-2022
Figure 173: Agilent Technologies, Inc.: Net Revenue (by Segment), $Million, 2020-2022
Figure 174: Agilent Technologies, Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 175: Agilent Technologies, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 176: Konica Minolta (Ambry Genetics, Inc.): Product Portfolio
Figure 177: Konica Minolta (Ambry Genetics, Inc.).: Overall Financials, $Million, 2020-2022
Figure 178: Konica Minolta (Ambry Genetics, Inc.): Net Revenue (by Segment), $Million, 2020-2022
Figure 179: Konica Minolta (Ambry Genetics, Inc.): Net Revenue (by Region), $Million, 2020-2022
Figure 180: Konica Minolta (Ambry Genetics, Inc.): R&D Expenditure, $Million, 2020-2022
Figure 181: BGI Genomics: Product Portfolio
Figure 182: BGI Genomics.: Overall Financials, $Million, 2020-2022
Figure 183: CENTOGENE N.V.: Product Portfolio
Figure 184: CENTOGENE N.V.: Overall Financials, $Million, 2020-2022
Figure 185: CENTOGENE N.V.: Net Revenue (by Segment), $Million, 2020-2022
Figure 186: CENTOGENE N.V.: Net Revenue (by Region), $Million, 2020-2022
Figure 187: CENTOGENE N.V.: R&D Expenditure, $Million, 2020-202
Figure 188: Eurofins Scientific SE: Product Portfolio
Figure 189: Eurofins Scientific SE: Overall Financials, $Million, 2020-2022
Figure 190: Eurofins Scientific SE: Net Revenue (by Segment), $Million, 2020-2022
Figure 191: Eurofins Scientific SE: Net Revenue (by Region), $Million, 2020-2022
Figure 192: GeneDx, Holdings Corp.: Product Portfolio
Figure 193: GeneDx, Holdings Corp.: Overall Financials, $Million, 2020-2022
Figure 194: GeneDx, Holdings Corp.: Net Revenue (by Segment), $Million, 2020-2022
Figure 195: GeneDx, Holdings Corp.: R&D Expenditure, $Million, 2020-2022
Figure 196: Azenta U.S., Inc. (GENEWIZ, Inc.): Product Portfolio
Figure 197: Azenta U.S., Inc. (GENEWIZ, Inc.): Overall Financials, $Million, 2020-2022
Figure 198: Azenta U.S., Inc. (GENEWIZ, Inc.): Net Revenue (by Segment), $Million, 2020-2022
Figure 199: Azenta U.S., Inc. (GENEWIZ, Inc.): Net Revenue (by Region), $Million, 2020-2022
Figure 200: Illumina, Inc.: Product Portfolio
Figure 201: Illumina, Inc.: Overall Financials, $Million, 2020-2022
Figure 202: Illumina, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 203: Illumina, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 204: Illumina, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 205: Invitae Corporation: Product Portfolio
Figure 206: Invitae Corporation: Overall Financials, $Million, 2020-2022
Figure 207: Invitae Corporation: Net Revenue (by Segment), $Million, 2020-2022
Figure 208: Invitae Corporation: Net Revenue (by Region), $Million, 2020-2022
Figure 209: Laboratory Corporation of America Holdings: Product Portfolio
Figure 210: Laboratory Corporation of America Holdings: Overall Financials, $Million, 2020-2022
Figure 211: Laboratory Corporation of America Holdings: Revenue (by Segment), $Million, 2020-2022
Figure 212: Laboratory Corporation of America Holdings: Revenue (by Region), $Million, 2020-2022
Figure 213: Medgenome: Product Portfolio
Figure 214: Myriad Genetics, Inc.: Product Portfolio
Figure 215: Myriad Genetics, Inc.: Overall Financials, $Million, 2020-2022
Figure 216: Myriad Genetics, Inc.: Net Revenue (by Segment), $Million, 2020-2022
Figure 217: Myriad Genetics, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 218: OPKO Health, Inc.: Product Portfolio
Figure 219: OPKO Health, Inc.: Overall Financials, $Million, 2020-2022
Figure 220: OPKO Health, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 221: PerkinElmer, Inc.: Product Portfolio
Figure 222: PerkinElmer, Inc.: Overall Financials, $Million, 2020-2022
Figure 223: PerkinElmer, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 224: PerkinElmer, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 225: PerkinElmer, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 226: Exact Sciences Corporation (Prevention Genetics): Product Portfolio
Figure 227: Exact Sciences Corporation: Overall Financials, $Million, 2020-2022
Figure 228: Exact Sciences Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 229: Exact Sciences Corporation: Revenue (by Region), $Million, 2020-2022
Figure 230: Exact Sciences Corporation: R&D Expenditure, $Million, 2020-2022
Figure 231: QIAGEN N.V.: Product Portfolio
Figure 232: QIAGEN N.V.: Overall Financials, $Million, 2020-2022
Figure 233: QIAGEN N.V.: Revenue (by Segment), $Million, 2020-2022
Figure 234: QIAGEN N.V.: Revenue (by Region), $Million, 2020-2022
Figure 235: QIAGEN N.V.: R&D Expenditure, $Million, 2020-2022
Figure 236: Quest Diagnostics Incorporated.: Product Portfolio
Figure 237: Quest Diagnostics Incorporated: Overall Financials, $Million, 2020-2022
Figure 238: Quest Diagnostics Incorporated: Revenue (by Segment), $Million, 2020-2022
Figure 239: Strand Life Science Pvt Ltd.: Product Portfolio
LIST OF TABLES
Table 1: Key Questions Answered in the Report
Table 2: Funding for Rare Disease Research
Table 3: Technological Advancements in the Rare Disease Genetic Testing Ecosystem
Table 4: Expansion of Medicare Coverage for Rare Disease Genetic Testing Tests (by Companies)
Table 5: North America Rare Disease Genetic Testing Market, Impact Analysis
Table 6: Europe Rare Disease Genetic Testing Market, Impact Analysis
Table 7: Asia-Pacific Rare Disease Genetic Testing Market, Impact Analysis
Table 8: Latin America Rare Disease Genetic Testing Market, Impact Analysis
Table 9: Rest-of-the-World Rare Disease Genetic Testing Market, Impact Analysis
Table 1: Key Questions Answered in the Report
Table 2: Funding for Rare Disease Research
Table 3: Technological Advancements in the Rare Disease Genetic Testing Ecosystem
Table 4: Expansion of Medicare Coverage for Rare Disease Genetic Testing Tests (by Companies)
Table 5: North America Rare Disease Genetic Testing Market, Impact Analysis
Table 6: Europe Rare Disease Genetic Testing Market, Impact Analysis
Table 7: Asia-Pacific Rare Disease Genetic Testing Market, Impact Analysis
Table 8: Latin America Rare Disease Genetic Testing Market, Impact Analysis
Table 9: Rest-of-the-World Rare Disease Genetic Testing Market, Impact Analysis
